Voluntary recall of selected batches of Sanofi Pasteur Vi polysaccharide typhoid vaccine, Typhim Vi® with potentially low antigen content

Sanofi Pasteur would like to notify healthcare professionals that they have recalled batches E1246-2, H0078-5, H0101-2 and G0461-2 of Vi polysaccharide typhoid vaccine (Typhim Vi®) as they have potentially lower than expected antigen content. This is due to heterogeneity at the end of the filling process of syringes and 20-dose vials. Healthcare professionals are advised that there is no safety concern to individuals who have received the affected batch of Typhim Vi® and Sanofi Pasteur does not recommend revaccination earlier than otherwise indicated for these individuals. Typhim Vi® vaccines from batches not affected by the recall can be administered. Please refer to the letter for more details.
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under 'For Healthcare Professionals’.

Step 2: Click on 'Restricted Content' and log in via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’.

Step 4: Click on the Drug Alert tab to view the DHCPLs.